Alvarez-Moreno, Carlos
Lavergne, Rose-Anne
Hagen, Ferry
Morio, Florent
Meis, Jacques F.
Le Pape, Patrice
Article History
Received: 11 August 2016
Accepted: 21 February 2017
First Online: 30 March 2017
Competing interests
: P.L.P. received grants from Astellas, Basilea and Pfizer. He is a consultant to Basilea and received speaker´s fees from Gilead, Basilea, Pfizer and MSD. C.A.M. has received grants from Pfizer and received speaker´s fees from Pfizer, MSD and Roche. J.F.M. received grants from Astellas, Basilea, and Merck. He has been a consultant to Astellas, Basilea, and Merck and received speaker´s fees from Merck and Gilead. F.M. received speaker´s fees from Basilea, MSD, and travel grants from Astellas, Gilead, MSD and Pfizer. R.A.L. received travel grants from Astellas and F.H. has no potential conflicts of interest.